Pharmacy Board recalls Allied Limited's nasal drops, Efinox
Health & Science
By
Esther Nyambura
| Nov 22, 2024
The Pharmacy and Poisons Board (PPB) has issued a recall for Efinox 1% and 0.5% nasal drops manufactured by Laboratory and Allied Limited.
In a statement on Friday, November 22, PPB CEO Fred Siyoi announced that the recall was prompted by a labeling and packaging mix-up that resulted in the strengths of the two drugs being interchanged.
"The Pharmacy and Poisons Board has mandated the recall of Efinox 1%, Batch No. 82979, and Efinox 0.5%, Batch No. 82978, manufactured by Laboratory and Allied Limited, Kenya. The recall is being issued due to labeling mix-ups where the correct product was identified, but the wrong strength was applied."
As a precaution, PPB has advised the public to discontinue the use, sale, and distribution of the affected products. Those in possession of the recalled batches are urged to return them to the nearest healthcare facility or supplier.
READ MORE
Relief for tea growers as prices rise at auction
Data laws, infrastructure gaps slow growth in AI and fintech sectors
Stalled border, poor roads hurt Mombasa transit cargo growth
Kenyan tech firm launches platform for people to co-own cloud servers
How developers can navigate funding challenges
Power of colourful exterior finishes on buildings, property
Tech, transparency driving brokers out of property market
Logistics firm Express Kenya unveils Sh13b real estate project
Ruto lures foreign investors to NSE with promise of Kenya Pipeline listing